ReviewOrphanet journal of rare diseases2021

New paradigms for the treatment of lysosomal storage diseases: targeting the endocannabinoid system as a therapeutic strategy.

Edward H Schuchman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.